Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/68993 |
Resumo: | The aim of Pharmaceutical Care programs is to improve patients' quality of life, and such programs are particularly effective in the case of chronic diseases such as hypertension. The objective of this longitudinal study was to analyze a Pharmaceutical Care model for hypertensive patients receiving care within the Family Health Strategy (FHS). All patients were being seen by an FHS team affiliated to a primary healthcare unit in Goiânia, Goiás, Brazil. Fourteen patients participated in the study, with each patient receiving six home visits during the Pharmaceutical Care. Overall, 142 drug-related problems were reported, the most common concerning the ineffectiveness of treatment (33.8%). A total of 135 pharmaceutical interventions were performed, 92.6% of which involved pharmacist-patient communication, with 48.8% of these interventions being implemented. Cardiovascular risk decreased in three patients and remained unchanged in nine. In hypertensive patients with diabetes, fasting glucose levels were reduced in six out of nine cases. The Pharmaceutical Care model proposed here was effective in detecting drug-related problems and in proposing interventions to resolve or prevent these problems. Consequently, this may have contributed towards improving clinical parameters, such as fasting glucose levels and cardiovascular risk in hypertensive patients receiving care within the FHS. |
id |
USP-31_ba6dace952be4ab6aee352602fda16f0 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/68993 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil Pharmaceutical careHypertensionPrimary health care The aim of Pharmaceutical Care programs is to improve patients' quality of life, and such programs are particularly effective in the case of chronic diseases such as hypertension. The objective of this longitudinal study was to analyze a Pharmaceutical Care model for hypertensive patients receiving care within the Family Health Strategy (FHS). All patients were being seen by an FHS team affiliated to a primary healthcare unit in Goiânia, Goiás, Brazil. Fourteen patients participated in the study, with each patient receiving six home visits during the Pharmaceutical Care. Overall, 142 drug-related problems were reported, the most common concerning the ineffectiveness of treatment (33.8%). A total of 135 pharmaceutical interventions were performed, 92.6% of which involved pharmacist-patient communication, with 48.8% of these interventions being implemented. Cardiovascular risk decreased in three patients and remained unchanged in nine. In hypertensive patients with diabetes, fasting glucose levels were reduced in six out of nine cases. The Pharmaceutical Care model proposed here was effective in detecting drug-related problems and in proposing interventions to resolve or prevent these problems. Consequently, this may have contributed towards improving clinical parameters, such as fasting glucose levels and cardiovascular risk in hypertensive patients receiving care within the FHS. A Atenção Farmacêutica tem como objetivo conseguir resultados concretos que melhorem a qualidade de vida do paciente, contribuindo especialmente em doenças crônicas, como a Hipertensão Arterial. O objetivo deste estudo foi analisar um modelo de Atenção Farmacêutica a pacientes com Hipertensão Arterial assistidos pela Estratégia Saúde da Família (ESF). Trata-se de um estudo longitudinal realizado com pacientes assistidos pela ESF de uma Unidade Básica de Saúde de Goiânia-GO. Participaram do estudo, 14 pacientes que receberam seis visitas domiciliares para Atenção Farmacêutica. Registraram-se 142 Problemas Relacionados a Medicamentos (PRM) sendo mais frequente a falta de efetividade do tratamento (33,8%). Realizaram-se 135 intervenções farmacêuticas, das quais 92,6% foram com a comunicação farmacêutico-paciente, em que 48,8% das intervenções foram implementadas. Observou-se redução do risco cardiovascular em três pacientes e nove pacientes não apresentaram alteração no nível de risco cardiovascular. Entre os pacientes hipertensos e diabéticos observou-se redução da glicemia de jejum em seis. O modelo de Atenção Farmacêutica proposto foi capaz de detectar PRM propondo intervenções para resolvê-los e preveni-los e, consequentemente, pode ter contribuído na melhora de parâmetros clínicos como glicemia de jejum e risco cardiovascular em pacientes hipertensos assistidos pela ESF. Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2013-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/6899310.1590/S1984-82502013000300023Brazilian Journal of Pharmaceutical Sciences; Vol. 49 Núm. 3 (2013); 609-618Brazilian Journal of Pharmaceutical Sciences; v. 49 n. 3 (2013); 609-618Brazilian Journal of Pharmaceutical Sciences; Vol. 49 No. 3 (2013); 609-6182175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/68993/71471Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessMartins, Bárbara Posse ReisAquino, Aline Teixeira deProvin, Mércia PandolfoLima, Dione MarçalDewulf, Nathalie de Lourdes SouzaAmaral, Rita Goreti2013-12-13T13:17:01Zoai:revistas.usp.br:article/68993Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2013-12-13T13:17:01Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil |
title |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil |
spellingShingle |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil Martins, Bárbara Posse Reis Pharmaceutical care Hypertension Primary health care |
title_short |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil |
title_full |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil |
title_fullStr |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil |
title_full_unstemmed |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil |
title_sort |
Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil |
author |
Martins, Bárbara Posse Reis |
author_facet |
Martins, Bárbara Posse Reis Aquino, Aline Teixeira de Provin, Mércia Pandolfo Lima, Dione Marçal Dewulf, Nathalie de Lourdes Souza Amaral, Rita Goreti |
author_role |
author |
author2 |
Aquino, Aline Teixeira de Provin, Mércia Pandolfo Lima, Dione Marçal Dewulf, Nathalie de Lourdes Souza Amaral, Rita Goreti |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Martins, Bárbara Posse Reis Aquino, Aline Teixeira de Provin, Mércia Pandolfo Lima, Dione Marçal Dewulf, Nathalie de Lourdes Souza Amaral, Rita Goreti |
dc.subject.por.fl_str_mv |
Pharmaceutical care Hypertension Primary health care |
topic |
Pharmaceutical care Hypertension Primary health care |
description |
The aim of Pharmaceutical Care programs is to improve patients' quality of life, and such programs are particularly effective in the case of chronic diseases such as hypertension. The objective of this longitudinal study was to analyze a Pharmaceutical Care model for hypertensive patients receiving care within the Family Health Strategy (FHS). All patients were being seen by an FHS team affiliated to a primary healthcare unit in Goiânia, Goiás, Brazil. Fourteen patients participated in the study, with each patient receiving six home visits during the Pharmaceutical Care. Overall, 142 drug-related problems were reported, the most common concerning the ineffectiveness of treatment (33.8%). A total of 135 pharmaceutical interventions were performed, 92.6% of which involved pharmacist-patient communication, with 48.8% of these interventions being implemented. Cardiovascular risk decreased in three patients and remained unchanged in nine. In hypertensive patients with diabetes, fasting glucose levels were reduced in six out of nine cases. The Pharmaceutical Care model proposed here was effective in detecting drug-related problems and in proposing interventions to resolve or prevent these problems. Consequently, this may have contributed towards improving clinical parameters, such as fasting glucose levels and cardiovascular risk in hypertensive patients receiving care within the FHS. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-09-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/68993 10.1590/S1984-82502013000300023 |
url |
https://www.revistas.usp.br/bjps/article/view/68993 |
identifier_str_mv |
10.1590/S1984-82502013000300023 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/68993/71471 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 49 Núm. 3 (2013); 609-618 Brazilian Journal of Pharmaceutical Sciences; v. 49 n. 3 (2013); 609-618 Brazilian Journal of Pharmaceutical Sciences; Vol. 49 No. 3 (2013); 609-618 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222911363022848 |